Prospective study of "door to needle time" in meningococcal disease

F A Riordan1, A P Thomson, J A Sills

  • 1Institute of Child Health, University of Liverpool.

Insights

Prompt antibiotic treatment for pediatric meningococcal disease is crucial. Most children received antibiotics in the emergency department within a median of 36 minutes, especially those with severe symptoms or a rash.

Area of Science:

  • Pediatric infectious diseases
  • Clinical pharmacology
  • Emergency medicine

Background:

  • Meningococcal disease poses a significant threat to children.
  • Timely antibiotic administration is critical for improving outcomes in pediatric meningococcal disease.

Purpose of the Study:

  • To evaluate the promptness of parenteral antibiotic administration in children diagnosed with meningococcal disease.
  • To identify factors influencing the time to antibiotic treatment.

Main Methods:

  • Prospective data collection of "door to needle time" for parenteral antibiotics in 100 children with meningococcal disease.
  • Study conducted across four hospitals in Merseyside, including children aged 3-168 months.
  • Analysis of treatment times based on presentation route (direct to A&E vs. GP referral) and clinical signs (e.g., petechial rash).

Main Results:

  • Median "door to needle time" was 36 minutes.
  • Children with a petechial rash received antibiotics within 60 minutes.
  • Antibiotic administration was significantly faster in severe cases (p=0.01) and slower in non-rash presentations (p=0.007).

Conclusions:

  • The majority of children with meningococcal disease received their first dose of parenteral antibiotics in the Accident and Emergency (A&E) department.
  • Heightened awareness and ongoing research improve treatment times for children with a petechial rash.
  • Educational strategies for both A&E staff and General Practitioners (GPs) are recommended to further enhance immediate treatment protocols.
Abstract